Patent details

Basic Information

Publication number:

EP2621516

PCT Application Number:

PCT/US/2011/053681

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118298256

PCT Publication Number:

WO/2012/044684

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INTERFERON-BETA FOR USE AS MONOTHERAPY OR IN COMBINATION WITH OTHER CANCER THERAPIES

French Title of Invention:

INTERFÉRON-BÊTA UTILISÉ EN TANT QUE MONOTHÉRAPIE OU EN COMBINAISON AVEC D'AUTRES CANCÉROTHÉRAPIES

German Title of Invention:

INTERFERON-BETA ZUR VERWENDUNG ALS MONOTHERAPIE ODER IN KOMBINATION MIT ANDEREN KREBSTHERAPIEN

SPC Number:

Dates

Filing date:

28/09/2011

Grant date:

22/06/2016

EP Publication Date:

22/06/2016

PCT Publication Date:

05/04/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/08/2013

EP B1 Publication Date:

22/06/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/09/2016

Expiration date:

28/09/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/09/2011

 

 

Name:

Biogen MA Inc.

Address:

250 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

BAKER Darren, P.

Address:

United States (US)

2

Name:

JOSEPH Ingrid, B.J.K.

Address:

United States (US)

3

Name:

WANG Xinzhong

Address:

United States (US)

Priority

Priority Number:

389009 P

Priority Date:

01/10/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/21;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages